Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2006; 12(16): 2610-2614
Published online Apr 28, 2006. doi: 10.3748/wjg.v12.i16.2610
Published online Apr 28, 2006. doi: 10.3748/wjg.v12.i16.2610
Toxicity | Grade | Control group | Study group | χ2value |
Leukopenia | I | 6 | 10 | |
II | 2 | 8 | 3.41 | |
III | 0 | 3 | ||
IV | 0 | 0 | ||
GI tract | I | 8 | 3 | |
II | 5 | 10 | ||
III | 5 | 6 | 0.66 | |
IV | 1 | 2 | ||
Proctitis | I | 10 | 9 | |
II | 6 | 8 | ||
III | 3 | 3 | 0.01 | |
IV | 0 | 0 | ||
Skin | I | 5 | 3 | |
II | 8 | 9 | ||
III | 12 | 11 | 0.00 | |
IV | 0 | 0 | ||
Peripheral neuropathy | I | 0 | 10 | |
II | 0 | 4 | 1.09 | |
III | 0 | 1 | ||
Bladder | I | 12 | 11 | |
II | 6 | 8 | ||
III | 2 | 1 | 0.27 | |
IV | 0 | 0 |
- Citation: Hu JB, Sun XN, Yang QC, Xu J, Wang Q, He C. Three-dimensional conformal radiotherapy combined with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer. World J Gastroenterol 2006; 12(16): 2610-2614
- URL: https://www.wjgnet.com/1007-9327/full/v12/i16/2610.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i16.2610